[In vivo resistance of Plasmodium falciparum to 4-aminoquinolines and to a sulfadoxine-pyrimethamine combination. II--The Emperatriz study, Maranhâo, 1983-1984].
Passos
A D
AD
Osanai
C H
CH
Reyes
S
S
D000293:Adolescent; D000328:Adult; D000655:Amodiaquine / Q000627:therapeutic use*; D000818:Animals; D001938:Brazil; D002738:Chloroquine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010963:Plasmodium falciparum / Q000187:drug effects*; D011739:Pyrimethamine / Q000627:therapeutic use*; D011897:Random Allocation; D013413:Sulfadoxine / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000627:therapeutic use*
D013424:Sulfanilamides; D000655:Amodiaquine; D013413:Sulfadoxine; D002738:Chloroquine; D011739:Pyrimethamine
Resistência in vivo do Plasmodium falciparum às 4-aminoquinoleínas e à associação sulfadoxina-pirimetamina. II--Estudo de Imperatriz, Maranhão, 1983-1984.